Stocks surged on Friday, with the S&P 500 soaring 2.13% as investors welcomed a break from tariff-driven turmoil. The market ...

The market for index funds continues to grow, and aside from the sheer variety of choices now available to retail investors, one of the biggest benefits has been steadily decreasing fees. In August ...

Financially, Annexon has a strong cash position, providing a runway of 5-8 quarters, but the stock trades almost at cash due ...

What is Guillain-Barré syndrome? Guillain-Barré syndrome (GBS) is also called acute inflammatory demyelinating polyradiculoneuropathy (AIDP). It's a neurological disorder in which the body's immune ...

Antoine Corbin Furthermore, while traditional green bonds are principle-based, the EU Green Bond Standard (EU GBS) is ...

“Our analysis of the Truist Card Data, which we use as a proxy for both Mobility and Delivery GB growth, indicates that ...

Reports say the firm has approached banks regarding the planned listing ...

Barre Syndrome (GBS) - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering. This comprehensive analysis of the Guillain-Barré Syndrome (GBS) pipeline is a testament to ...

With this collaboration, investors, the Mirae Asset says, have a more stable investment alternative that can be used as a ...

Annexon Biosciences, Inc. ( ($ANNX) ) has released its Q4 earnings. Here is a breakdown of the information Annexon Biosciences, Inc. presented to ...